The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.

The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.

Show other versions (1)

Recent data show that corticolimbic expression of the effector immediate early gene Arc is up-regulated by standard antidepressant drugs. Here, we tested the effect upon Arc expression of a novel antidepressant and selective 5-hydroxytryptamine/noradrenaline reuptake inhibitor (SNRI), (-)1-(1-dimeth...

Bibliografske podrobnosti
Main Authors:	Pei, Q, Sprakes, M, Millan, M, Rochat, C, Sharp, T
Format:	Journal article
Jezik:	English
Izdano:	2004

Podobne knjige/članki

The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.
od: Pei, Q, et al.
Izdano: (2004)

The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex (vol 489, pg 179, 2004)
od: Pei, Q, et al.
Izdano: (2004)

Erratum: The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex (European Journal of Pharmacology (2004) 489 (179-185) DOI: 10.1016/j.ejphar.2004.03.002)
od: Pei, Q, et al.
Izdano: (2004)

Monoamine depletion by reuptake inhibitors
od: Hinz M, et al.
Izdano: (2011-10-01)

Antidepressant drug treatment induces Arc gene expression in the rat brain.
od: Pei, Q, et al.
Izdano: (2003)

Monoamine Depletion by Reuptake Inhibitors [Retraction]
od: Hinz M, et al.
Izdano: (2020-12-01)

Monoamine Depletion by Reuptake Inhibitors [Expression of Concern]
od: Hinz M, et al.
Izdano: (2020-04-01)

Monoamine Reuptake Inhibitors in Parkinson’s Disease
od: Philippe Huot, et al.
Izdano: (2015-01-01)

Antidepressant stimulation of CDP-diacylglycerol synthesis does not require monoamine reuptake inhibition
od: Aboukhatwa Marwa A, et al.
Izdano: (2010-01-01)

Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex.
od: Pei, Q, et al.
Izdano: (2004)

Implications for Combination Therapy of Selective Monoamine Reuptake Inhibitors on Dopamine Transporters
od: Hyomin Ahn, et al.
Izdano: (2023-10-01)

Suicide attempt with selective serotonin reuptake inhibitor antidepressants
od: Sandra Cuenca Carcelén, et al.
Izdano: (2021-01-01)

Synthesis and evaluation of variably substituted N-methyl tetrahydroisoquinolines and benzazepines as monoamine reuptake inhibitors
od: Sneh Lata, et al.
Izdano: (2022-01-01)

Effect of chronic electroconvulsive shock and antidepressant drugs on mRNA expression of AMPA receptor subunits in the rat brain
od: Pei, Q, et al.
Izdano: (2001)

Analytical methods for determination of selective serotonin reuptake inhibitor antidepressants
od: Şentürk Zühre, et al.
Izdano: (2011-06-01)

Chirality Matters: Fine-Tuning of Novel Monoamine Reuptake Inhibitors Selectivity through Manipulation of Stereochemistry
od: Predrag Kalaba, et al.
Izdano: (2023-09-01)

A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD
od: Wesnes Keith, et al.
Izdano: (2008-06-01)

Effect of chronic electroconvulsive shock and antidepressant drug treatment on VGlut1 mRNA expression in rat brain regions
od: Tordera, R, et al.
Izdano: (2003)

Antidepressants are selective serotonin neuronal reuptake inhibitors: 40-year history
od: D. S. Danilov
Izdano: (2015-03-01)

Selective serotonin reuptake inhibitor (SSRI) antidepressants, prolactin and breast cancer
od: Janet eAshbury, et al.
Izdano: (2012-12-01)

Serotonin reuptake inhibitors in Obsessive-Compulsive Disorder: antidepressant or antiobsessional agents?
od: Giuseppe Maina, et al.
Izdano: (2009-03-01)

WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
od: Geddes, J, et al.
Izdano: (2006)

Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?
od: Hugo R. Arias, et al.
Izdano: (2021-04-01)

Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.
od: Serres, F, et al.
Izdano: (2012)

Effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor, on monoamine system in mice and rats
od: Rui Xue, et al.
Izdano: (2016-01-01)

Effects of Monoamines and Antidepressants on Astrocyte Physiology: Implications for Monoamine Hypothesis of Depression
od: Swananda V Marathe, et al.
Izdano: (2018-07-01)

Research progress of non-monoamine antidepressants
od: Huan Zhang, et al.
Izdano: (2021-12-01)

Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
od: Barbui, C, et al.
Izdano: (2000)

Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)
od: Bruno P. Guiard, et al.
Izdano: (2011-01-01)

Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.
od: Fei Shen, et al.
Izdano: (2013-01-01)

Effect of paroxetine in combination with the 5-HT1A antagonists, NAD-299 and LY 426965, on expression of the immediate early gene arc in the rat brain
od: Tordera, R, et al.
Izdano: (2002)

Selective serotonin reuptake inhibitors. Drugs related to tricyclic antidepressants are a mixed bag.
od: Cowen, P, et al.
Izdano: (1994)

Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis.
od: Taylor, M, et al.
Izdano: (2006)

WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
od: Barbui, C, et al.
Izdano: (2006)

Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate-early gene Arc in rat brain.
od: Tordera, R, et al.
Izdano: (2003)

Hazard Characterization of Synthetic Cathinones Using Viability, Monoamine Reuptake, and Neuronal Activity Assays
od: Anne Zwartsen, et al.
Izdano: (2020-01-01)

Serotonin and norepinephrine reuptake inhibitor antidepressants: a look through the prism of their 30-year history
od: D. S. Danilov
Izdano: (2018-12-01)

A Bibliometric Analysis of the WoSCC Literature on the Use of Selective Serotonin Reuptake Inhibitors as Antidepressants
od: Li J, et al.
Izdano: (2024-11-01)

Efficacy of selective serotonin reuptake inhibitors-related antidepressants in Alzheimer’s disease: a meta-analysis
od: Haiyan Wang, et al.
Izdano: (2024-08-01)

Antagonization of monoamine reuptake transporters by agmatine improves anxiolytic and locomotive behaviors commensurate with fluoxetine and methylphenidate
od: Hira Rafi, et al.
Izdano: (2021-04-01)